Skip to main content

Multiple Myeloma

Multiple Myeloma, Oncology
Dissecting the Treatment Costs of Newly Diagnosed Myeloma in First 2 Years
Read More
Multiple Myeloma, Oncology
New Data on Ixazomib Maintenance Support Long-Term Oral Therapy in Patients with Myeloma
Kate Smith
Read More
Multiple Myeloma, Oncology
Novel Oral Proteasome Inhibitor Oprozomib Shows Promise in Myeloma
Read More
Multiple Myeloma, Oncology
Weekly Carfilzomib Safe and Effective
Kate Smith
Read More
Multiple Myeloma, Oncology
Monoclonal Antibodies Poised to Be “Blockbusters” in Myeloma
Kate Smith
Read More
Multiple Myeloma, Oncology
Novel Drug Classes Make News in Multiple Myeloma
Caroline Helwick
Read More
Multiple Myeloma, Oncology
Myeloma Drug Arsenal Expanding to New Classes
Caroline Helwick
Read More
Multiple Myeloma, Oncology
Lenalidomide Maintenance in Transplant-Eligible Myeloma Population Still Debated
Caroline Helwick
Read More
Multiple Myeloma, Oncology
FIRST Trial Shows Value for Continued Use of Lenalidomide in Transplant-Ineligible Patients with Newly Diagnosed Myeloma
Caroline Helwick
Read More
Multiple Myeloma, Oncology
Oral Proteasome Inhibitor MLN9708 a News Maker at ASH 2012
Caroline Helwick
Read More
Page 4 of 6
Results 31 - 40 of 53